2025-10-20 - Analysis Report
Okay, let's analyze Intuitive Surgical (ISRG) based on the data provided.

**Executive Summary:**

Intuitive Surgical (ISRG) specializes in robotic surgical systems, most notably the da Vinci Surgical System. While ISRG has delivered substantial growth in the past, recent performance shows some divergence from the S&P 500.  Current indicators suggest a cautiously optimistic outlook, but with considerable debate among analysts.

---

**1. Performance Relative to S&P 500 (VOO)**

*   **Cumulative Returns:** ISRG = 66.19%, VOO = 97.05%
*   **Difference:** ISRG underperformed VOO by -30.9%.
*   **Relative Divergence:** 5.0 (Indicates ISRG's underperformance is near the lower end of its historical divergence range).

**Analysis of Alpha, Beta, CAGR, MDD:**

| Year       | CAGR    | MDD     | Alpha   | Beta    | Cap(B) |
|------------|---------|---------|---------|---------|--------|
| 2015-2017  | 68.0%   | 77.6%   | 40.0%   | -0.1    | 43.6   |
| 2016-2018  | 64.0%   | 72.2%   | 49.0%   | -0.0    | 57.2   |
| 2017-2019  | 54.0%   | 72.2%   | 31.0%   | 0.2     | 70.6   |
| 2018-2020  | -6.0%   | 80.4%   | -29.0%  | 0.3     | 97.8   |
| 2019-2021  | 29.0%   | 80.4%   | -18.0%  | 0.6     | 128.8  |
| 2020-2022  | -23.0%  | 80.4%   | -22.0%  | 1.2     | 95.1   |
| 2021-2023  | -17.0%  | 77.5%   | -18.0%  | 1.7     | 120.9  |
| 2022-2024  | 36.0%   | 77.5%   | 15.0%   | 1.7     | 187.1  |
| 2023-2025  | 28.0%   | 72.7%   | -33.0%  | 0.8     | 159.9  |

**Analysis:**

*   **CAGR Trend:** The Compound Annual Growth Rate (CAGR) has fluctuated significantly, showing periods of high growth followed by declines.  The recent trend suggests a potential recovery.
*   **Maximum Drawdown (MDD):** The MDD remains consistently high, indicating significant price volatility and risk.
*   **Alpha:** The Alpha values have been negative in many recent periods, indicating underperformance relative to the benchmark (S&P 500) on a risk-adjusted basis.
*   **Beta:** The Beta has been increasing, suggesting that ISRG's price is becoming more sensitive to market movements.  A Beta above 1 indicates higher volatility than the S&P 500.
*   **Cap(B):**  Market capitalization has generally increased over time, reflecting overall company growth.

**2. Recent Stock Price Movements**

*   **Current Price:** $446.13
*   **Previous Close:** $434.62
*   **Change:** +2.65% (Significant positive change reflecting recent positive market activity.)
*   **5-day Moving Average:** 437.70
*   **20-day Moving Average:** 441.65
*   **60-day Moving Average:** 459.63

**Analysis:** The price is above both the 5-day and 20-day moving averages, suggesting short-term upward momentum. However, it's still below the 60-day moving average, indicating potential resistance at that level. The large positive change from the previous close may indicate a short-term rally.

**3. Indicators**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment Recommended - nearing Very Risky territory)
*   **RSI:** 50.98 (Neutral - Neither overbought nor oversold)
*   **PPO:** 0.22 (Positive, but low. Indicates that the shorter moving average is slightly above the longer moving average)
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash
*   **Recent (20-day) Relative Divergence Change:** 2.0 (+) (Indicates short-term improvement in performance relative to the benchmark)
*   **Expected Return:** 243.1% (Potentially very high long-term return compared to the S&P 500 if investing from now)

**Analysis:**

* The MRI suggests that the stock is nearing Very Risky territory.
*   The RSI is neutral.
*   The PPO is slightly positive but low.
*   The recent change in relative divergence is a positive sign, indicating some improvement in performance compared to the S&P 500.
*   The exceptionally high expected return should be viewed with caution; long-term projections are subject to significant uncertainty.

**4. Recent News & Significant Events**

*   **Tesla, Netflix Earnings:** (Indirect - General market context)
*   **Opportunity After Pullback? (Simply Wall St.):**  Suggests the recent price decrease might present a buying opportunity.
*   **Growth Stock (Motley Fool):** ISRG is mentioned as a growth stock.
*   **Jim Cramer: "Don't Buy Me" (Insider Monkey):** Negative sentiment from a prominent market commentator.
*   **Inflation Data, Intel and Tesla Earnings:** (Indirect - Macroeconomic context)
*   **Intuitive Surgical Pre-Q3 Analysis (Zacks):** Potentially provides a deeper look into ISRG's prospects.

**Analysis:** The news is mixed.  Some articles suggest a buying opportunity, while others express caution. Jim Cramer's negative opinion is a factor to consider.  The upcoming earnings and broader market conditions related to inflation are relevant.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.94)
*   **Target Price:** Avg: $568.40, High: $685.00, Low: $350.00
*   **Opinions:** 27
*   **Recent Rating Changes:**  No specific changes listed

**Analysis:**  Analysts generally have a positive outlook on ISRG, with a "Buy" consensus and a significant average target price above the current price. However, the wide range in target prices indicates some uncertainty among analysts. The absense of specific recent rating changes indicates relative stability in analyst sentiment.

**5. Recent Earnings Analysis**

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-07-23   | 1.84  | 2.44 B$   |
| 2025-04-23   | 1.95  | 2.25 B$   |
| 2024-10-18   | 1.59  | 2.04 B$   |
| 2024-07-19   | 1.48  | 2.01 B$   |
| 2025-07-23   | 1.48  | 2.01 B$   |

**Analysis:**

*   **EPS Trend:**  EPS has shown some fluctuation, with a recent peak followed by a slight decrease. The most recent EPS is lower than the previous quarter but higher than the same quarter of the previous year.
*   **Revenue Trend:** Revenue generally shows an upward trend, indicating growth in sales.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $2.44B   | 66.31%        |
| 2025-03-31   | $2.25B   | 64.69%        |
| 2024-12-31   | $2.41B   | 68.04%        |
| 2024-09-30   | $2.04B   | 67.41%        |
| 2024-06-30   | $2.01B   | 68.30%        |

**Capital and Profitability**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-06-30   | $17.85B  | 3.69%    |
| 2025-03-31   | $17.11B  | 4.08%    |
| 2024-12-31   | $16.43B  | 4.17%    |
| 2024-09-30   | $15.58B  | 3.63%    |
| 2024-06-30   | $14.71B  | 3.58%    |

**Analysis:**

*   **Revenue:**  Revenue has been generally increasing, indicating growth in the company's top line.
*   **Profit Margin:** Profit margins remain very high, demonstrating the company's pricing power and efficiency.
*   **Equity:** Equity is steadily increasing, reflecting the accumulation of retained earnings.
*   **ROE:** Return on Equity (ROE) is relatively stable, indicating consistent profitability relative to shareholder equity.

**7. 종합 분석**

Intuitive Surgical is a fundamentally strong company with high profit margins and revenue growth. However, recent stock performance has lagged the S&P 500, and the technical indicators paint a mixed picture.

*   **Positives:** Strong financials, high profit margins, increasing revenue, analyst consensus is "Buy," potential buying opportunity after pullback.
*   **Negatives:**  Underperformance relative to S&P 500, high volatility (MDD), negative Alpha in recent periods, increasing Beta, mixed news sentiment (Jim Cramer's negative view), recent earnings slightly down.

**Recommendation:**

The data suggests a cautious approach. While the long-term expected return is attractive, the underperformance relative to the S&P 500 and mixed signals warrant careful consideration.  A potential strategy could be to monitor the stock closely, especially leading up to the next earnings release, and consider a gradual accumulation of shares if positive trends emerge. It would be wise to follow further news, SEC filings, or analyst ratings. The high variance in analyst price targets should warn you about the potential for unpredictable price movements.

